By Alex Berenson
Pfizer Drug Dealt Blow in Testing
READ MORE


By Jeff Ventura
Researchers at the Johns Hopkins University School of Medicine say that how fast the amount of PSA (prostate-specific antigen) in a man's blood increases, or PSA velocity (PSAV), is an accurate gauge of tumor aggression and danger, even when PSA levels
READ MORE


By Nicholas Bakalar
One or two alcoholic drinks a day can further reduce the likelihood of heart attack even in men who are already at low risk, new research suggests.
READ MORE


By Barnaby Feder
Doctors Rethink Widespread Use of Heart Stents
READ MORE


By Roni Rabin
Value of Cholesterol Targets Is Disputed
READ MORE


By Barnaby Feder
Newer Stents Pose Dangers, 2 Doctors Say
READ MORE


By Michael Mason
Outlandish portions. Sky-high salt content. Employees who don’t wash their hands. There are hazards aplenty at your favorite restaurant, but now health officials in New York and Chicago believe that they have cornered a real killer in the kitchen
READ MORE


By David Greenberg
When interpreting prostate cancer screening test results, physicians should consider the impact of a patient's body mass index, regardless of race, according to a new study.
READ MORE


By Toni Baker
If he can figure out which babies will be born unable to breathe properly, Dr. Stephen M. Black thinks he can help change that.
READ MORE


By Gina Kolata
Mary Wittenberg, the 44-year-old president of New York Road Runners, is a fast, strong and experienced runner. But she races best, she says, when she runs just behind Witold Bialokur. He can run 10 kilometers, or 6.2 miles, in less than 44 minutes and
READ MORE


By
Bayer A.G.’s limp excuse for withholding data suggesting that a heart-surgery drug is dangerous won’t wash. The failure by the German pharmaceutical giant to inform the Food and Drug Administration of the disquieting results of a large obse
READ MORE


By Science Daily
In the first randomized trial of its kind, Tadalafil, a drug typically prescribed for erectile dysfunction in men, has been proven to increase the sexual function of prostate cancer survivors
READ MORE


By Branwen Morgan
Prostate cancer researchers at Sydney's Garvan Institute, supported by the Cancer Institute NSW, have found a new marker for identifying aggressive prostate cancers.
READ MORE


By Elisabeth Rosenthal
Every patient in the cardiac care unit at the San Filippo Neri Hospital who survives a heart attack goes home with a prescription for purified fish oil, or omega-3 fatty acids.
READ MORE


By Science Daily
A new McGill University study that used thermal imaging technology for the first time ever to measure sexual arousal rates has turned the conventional wisdom that women become aroused more slowly than men on its head.
READ MORE


By Julie Moore
In the first randomized trial of its kind, Tadalafil, a drug typically prescribed for erectile dysfunction in men, has been proven to increase the sexual function of prostate cancer survivors, according to a study released today from the International
READ MORE


By
F.D.A. Says Bayer Failed to Reveal Drug Risk Study
READ MORE


By Gracie Gutierrez
Researchers at Baylor College of Medicine (BCM) are hoping a new gene therapy that takes a gene called RTVP-1 directly into the prostate tumor will prove effective in preventing recurrence of the disease.
READ MORE


By Science Daily
Study Shows Men With Erectile Dysfunction Favor Treatment With Vardenafil
READ MORE


By Leah Gourley
A treatment mainstay for prostate cancer puts men at increased risk for diabetes and cardiovascular disease, according to a large observational study published in the Sept. 20 Journal of Clinical Oncology.
READ MORE


<<... <... 624 625 626 627 628 629 630 631 632 633 ...> ...>>
 
 
 
Patent Pending:   60/481641
 
Copyright © 2024 NetDr.com. All rights reserved.